| |
|
|
| |
| |
| |
| Monday Morning Messages |
| |
| 20th May 2024
|
|
|
|
|
|
| |
|
| |
|
Fellowship of the Royal Society
|
| |
|
|
|
|
|
Many congratulations to Professor Sir Andrew Pollard, Director of the Oxford Vaccine Group who was elected a Fellow of the Royal Society, one of the highest honours in science.
|
|
|
|
|
|
|
|
|
|
Staff and students in the department are invited to join the University's LGBT+ (*) network, bringing together employees of the University of Oxford, Oxford University Press, colleges, nurseries and postgraduate students. The network uses an email list and teams channel to send out news and holds various meetings throughout the year, both social and work-related.
* The + represents minority gender identities and sexual orientations not included explicitly in the acronym LGBT.
|
|
|
|
|
|
|
|
|
| An online dashboard has been launched showing England-wide responses to a survey of participants’ experiences of taking part in health research. The dashboard allows users to view results by criteria including study, site, trust and clinical speciality from more than 100,000 survey responses. The survey is provided by the National Institute for Health and Care Research (NIHR) to NHS trusts and other providers to support improvements for NIHR-backed trials. Staff with approved email suffixes, including nihr.ac.uk, nhs.uk and ac.uk, can create an account to view the data. |
|
|
|
|
| |
| |
|
|
|
|
|
| Open and responsible research |
| |
|
Applications are open for the Oxford | Berlin Summer School on Open and Responsible Research, which will take place from 9 to 14 September 2024 in Berlin. This event will train researchers to become leaders in open research practices and help them foster a culture of responsibility in research. Early career researchers are especially encouraged. Apply by the 31st of May. Travel stipends available to Oxford staff and students.
|
|
|
|
|
|
|
|
|
Join Focus at a half-day Continuous Improvement roadshow which includes workshops to introduce tools for enhancing efficiency in our daily work, and a showcase with case studies from colleagues, about the power of Continuous Improvement at Oxford.
Date: 20 June and 4 July
Time: 9:30- 1:00 (both events)
Venue: Old Road Campus (20 June) and City centre (4 July) |
|
|
|
|
| |
| |
|
Department of Paediatrics' Garden Party 2024
|
| |
|
|
|
|
|
|
| Sign up now to join colleagues and friends across the department for the annual Paediatrics' Garden Party. This year's event will feature live music, games, a BBQ lunch and the opportunity to go punting. Please ensure you register to secure your place as capacity is limited and places will be allocated on a first come first served basis. The closing date for registration is 20th June. |
|
|
|
|
| |
| |
|
|
|
|
| Newton-Abraham Lecture 2024 |
| |
|
21 May 2024 | Maths Institute | 5pm
Listen to Professor Johannes van den Anker M.D., Ph.D., who holds the Evan and Cindy Jones Professorship in Paediatric Clinical Pharmacology at the Children's National Hospital in Washington D.C, talk about How clinical pharmacology can take pregnant women and their neonates to its bosom. A drinks reception will follow the lecture. |
|
|
|
|
| |
| |
|
|
|
|
| Bridging the divide: Translational research with a canine model of Duchenne Muscular Dystrophy |
| |
|
22 May 2024 | IDRM | 12.30pm
There is no cure for the fatal and devastating childhood onset, X-linked disorder, Duchenne Muscular Dystrophy (DMD). Many groups, are evaluating novel and sometimes sophisticated treatments, either with a view to replace the absent protein, dystrophin, or to mitigate against the deleterious effects of its loss. Richard Piercy, Professor of Comparative Neuromuscular Disease at the Royal Veterinary College, will discuss the founding of the DE50-MD canine model of DMD, maintained at the Royal Veterinary College, studies conducted that make this arguably the best characterised large animal model of this disorder and our use of the model in clinical veterinary trials, including in gene editing and gene therapies. Students/postdocs can sign up for lunch immediately following the talk here - https://forms.office.com/e/0rK0YxZDvC |
|
|
|
|
| |
| |
|
|
|
|
| Oxford Biomedical Research Centre and BRC Open Day |
| |
|
30 May 2024 | Westgate Centre | 10am - 3.30pm
Step into the future of healthcare at this Open Day event where you can experience interactive stands showcasing the ground-breaking research that is driving change for NHS patients. Learn more about new diagnostics and revolutionary treatments, and discover how YOU can play a part in shaping the future of medicine by participating in our research.
The directors of the two BRCs: Professor Helen McShane and Professor John Geddes, will officially open the event.
|
|
|
|
|
| |
| |
|
|
|
|
| Wearables in mega-scale biobanks - are there some learnings for rare disease research? |
| |
|
10 June 2024 | Richard Doll Lecture Theatre | 11am
Professor Aiden Doherty, Wellcome Trust Senior Research Fellow and Professor of Biomedical Informatics at the University of Oxford, will discuss the story behind the collection of wrist-worn accelerometer data in over 150,000 research participants across the UK and China, while also describing efforts to collect complementary open human activity recognition validation datasets to further enhance these resources. |
|
|
|
|
| |
| |
|
|
|
|
| New Therapeutic Approaches in Translational Mental Health |
| |
|
16 September 2024 | Maths Institute | All day
This in-person conference is hosted by the Oxford Health BRC and sponsored by the UK Mental Health Mission. The event aims to bring together industry, academic & clinical researchers, the regulator and government research funding organisations to discuss the current challenges facing therapeutic development. The overall objective is to forge collaborations that can increase capacity and capability through partnerships to deliver paradigm changes in translational mental health research. The event includes keynotes, lightning talks, roundtable discussion and industry led workshop sessions by Angelini Pharma, Big Health, Boehringer Ingelheim, Karuna Therapeutics and Reckitt Benckiser. |
|
|
|
|
| |
| |
|
|
|
|
|
|
|
Oxford Vaccine Group would like to invite you to take part in a study investigating how two common respiratory germs alter the environment in your nose and impact human health. The knowledge gathered in this project could be used to help develop new interventions such as anti-virus agents and drugs targeting the host body response. If you are 18 to 55 years old, you may be eligible to take part. We will provide reimbursement for your time, inconvenience and travel. The study duration is approximately 10 weeks.
If you would like to find out more, please read the Participant Information Sheet. If you are interested in joining the study, please visit the Pre-screening Questionnaire where you can access the online screening questions and register your interest.
Email info@ovg.ox.ac.uk, Tel: 01865 611400 |
|
|
|
|
|
|
|
|
|
